Thermo Fisher Scientific Opens New Manufacturing Facility in China
Expands Global Footprint, Local Production Capabilities to Address Increased Demand from Life Sciences Customers in China and Asia-Pacific Region
Thermo Fisher Scientific Inc. announced the official opening of its new facility in Suzhou, China, for the manufacturing of Life Sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.
Since entering the Chinese market 30 years ago, Thermo Fisher Scientific has established a strong research and development, manufacturing and commercial infrastructure in China, becoming one of the largest companies serving the life sciences market in the region. Most recently, Thermo Fisher has invested nearly $20 million in the 12,000-square-meter Suzhou plant, which will house more than 150 employees and has room for expansion. From this geographically central location, the new facility will primarily serve the life sciences and pharmaceutical industries, including research, diagnostics and bioproduction, as well as customers in the chemical, environmental and electronics industries.
In Suzhou, Thermo Fisher will manufacture plastic labware and consumables, including sample preparation products and filterware, as well as laboratory refrigerators, freezers, incubators and centrifuges. To ensure an environmentally friendly and safe work environment, the new facility will follow the best global and local manufacturing practices, including ISO9001, ISO14001 and ISO13485 standards.
“China is one of our fastest-growing markets and has been a key contributor to our success,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The Suzhou facility builds on our well-established presence in China and is an important next step as we closely align our depth of capabilities with China’s five-year plan to develop strategic industries, including pharmaceutical, healthcare and environmental.”
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
